Evidence lead: Ranks seven through ten · High appeal-filing share
Health Alliance Plan MA: Appeals followed a large share of denials
593 appeals equal 15.0% of this contract's recorded denials. That is rank #9 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks seven through ten · High appeal-filing share
Appeals followed a large share of denials
593 appeals equal 15.0% of this contract's recorded denials. That is rank #9 of 37 for filing share. The ratio reports aggregate activity; it cannot reveal why an appeal was or was not filed, whether the underlying cases were comparable, or what happened outside the reporting window.
Ranks twenty-six through thirty · Lower-middle denial cohort
Below the center of the denial-rate ordering
At 5.9%, this contract sits in the lower-middle part of the observed distribution. The exact rank is #28 of 37. This is aggregate prior-authorization activity for the reporting window, not a probability that a particular service, drug, or beneficiary request will be denied.
Ranks twenty-six through thirty · Moderate request-volume cohort
A mid-lower authorization workload
This contract's 67,000 requests form a moderate comparison base within the table. Its request-volume rank is #26 of 37. Volume shows the denominator behind approvals and denials; it is not a measure of plan quality, membership, benefit breadth, price, or future coverage decisions.
Ranks eleven through fifteen · Upper-middle overturn cohort
Appeal overturns ran above most contracts
The observed overturn rate is 74.0%, in the upper-middle portion of the table. Its overturn-rate rank is #12 of 37. The denominator is filed appeals, not all authorization requests. The percentage therefore describes reviewed appeals and must not be read as an individual outcome forecast.
Ranks eleven through fifteen · Upper-middle reversal reach
Reversals covered an above-median share of denials
Overturned appeals represent 11.1% of all denials here, based on 439 reversals. The cross-contract rank is #12 of 37. This derived measure combines appeal filing and outcome, so it supplies scale context but does not identify clinical reasons, administrative errors, or coverage rules.